Functional Analysis of Genetic Variation in Catechol-O-Methyltransferase (COMT): Effects on mRNA, Protein, and Enzyme Activity in Postmortem Human Brain
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Catechol-O-methyltransferase (COMT) is a key enzyme in the elimination of dopamine in the prefrontal cortex of the human brain. Genetic variation in the COMT gene (MIM 116790) has been associated with altered prefrontal cortex function and higher risk for schizophrenia, but the specific alleles and their functional implications have been controversial. We analyzed the effects of several single-nucleotide polymorphisms (SNPs) within COMT on mRNA expression levels (using reverse-transcriptase polymerase chain reaction analysis), protein levels (using Western blot analysis), and enzyme activity (using catechol methylation) in a large sample (n = 108) of postmortem human prefrontal cortex tissue, which predominantly expresses the -membrane-bound isoform. A common coding SNP, Val158Met (rs4680), significantly affected protein abundance and enzyme activity but not mRNA expression levels, suggesting that differences in protein integrity account for the difference in enzyme activity between alleles. A SNP in intron 1 (rs737865) and a SNP in the 3' flanking region (rs165599)--both of which have been reported to contribute to allelic expression differences and to be associated with schizophrenia as part of a haplotype with Val--had no effect on mRNA expression levels, protein immunoreactivity, or enzyme activity. In lymphocytes from 47 subjects, we confirmed a similar effect on enzyme activity in samples with the Val/Met genotype but no effect in samples with the intron 1 or 3' SNPs. Separate analyses revealed that the subject's sex, as well as the presence of a SNP in the P2 promoter region (rs2097603), had small effects on COMT enzyme activity. Using site-directed mutagenesis of mouse COMT cDNA, followed by in vitro translation, we found that the conversion of Leu at the homologous position into Met or Val progressively and significantly diminished enzyme activity. Thus, although we cannot exclude a more complex genetic basis for functional effects of COMT, Val is a predominant factor that determines higher COMT activity in the prefrontal cortex, which presumably leads to lower synaptic dopamine levels and relatively deleterious prefrontal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A polymorphism of COMT with decreased function (Chen et al., 2004), was associated with increased activation of the IFG during action cancelation (Congdon et al., 2009) and decreased interference inhibition (Solis-Ortiz et al., 2010), although conflicting results have also been reported (Kramer et al., 2007).”
From Response Inhibition and Interference Control in Obsessive–Compulsive Spectrum Disorders (2014) · cites this paper as Chen et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“The COMT enzyme plays a significant role in regulating frontal DA (Chen et al., 2004)”
From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Chen et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“The common rs4680 Val 158 Met single nucleotide polymorphism (SNP) leads to a reduction of COMT enzymatic activity in Met carriers (6-8).”
From Influence of the COMT genotype on working memory and brain activity changes during development (2011) · cites this paper as [6]
In the citing paper
“The COMT val allele is associated with high enzymatic activity and consequently low synaptic dopamine levels, whereas the COMT met allele results in approximately one third less enzyme activity and consequently high synaptic dopamine (Chen, Lipska et al. 2004).”
From Developmental imaging genetics: Linking dopamine function to adolescent behavior (2014) · cites this paper as Chen, Lipska et al. 2004
In the citing paper
“which are responsible for the bulk of dopamine degradation in the striatum and the prefrontal cortex respectively”
From DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls (2010) · cites this paper as Chen et al, 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Self-citationSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Self-citationEnzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283 · cited 1×
“Since its discovery in 1958 (Axelrod and Tomchick 1958), catechol-O-methyltransferase (COMT) has been an important enzyme in catecholamine biochemistry and pharmacology and, more recently, in genetic mechanisms of variation in catechol metabolism and its clinical implications.”
BackgroundLotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., & Taskinen, J. (1995) · Biochemistry · doi:10.1021/bi00013a008 · Cited by 1,167
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893 · cited 1×
“Indeed, clinical studies of COMT have revealed that the Met allele, which encodes the enzyme with lower activity, is associated with better performance on tests of prefrontally mediated cognition (Egan et al. 2001; Goldberg et al. 2003; Mattay et al. 2003; Diamond et al. 2004; Nolan et al. 2004).”
BackgroundSelf-citationGogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Self-citation
Cited by
Items 901–1,000 of 1,003
Erickson, K. I. (2008) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.009.2008 · Cited by 17
Kant, T., Koyama, E., Zai, C. C., Beitchman, J. H., & Kennedy, J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031782 · Cited by 16
Yang, L., Dai, X., Wu, L., Xu, T., Chen, Z., Min, Z., Liao, Y., Ni, L., Yao, Y., Yi, G., et al. (2021) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2021.113868 · Cited by 17
Naudts, K. H., Azevedo, R. T., David, A. S., Heeringen, C. V., & Gibbs, A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111416688 · Cited by 16
Jaspar, M., Dideberg, V., Bours, V., Maquet, P., & Collette, F. (2015) · Brain and Cognition · doi:10.1016/j.bandc.2015.01.013 · Cited by 16
Jongkees, B. J., Hommel, B., & Colzato, L. S. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01101 · Cited by 16
Ihne, J. L., Gallagher, N. M., Sullivan, M. E., Callicott, J. H., & Green, A. E. (2015) · Cortex · doi:10.1016/j.cortex.2015.10.025 · Cited by 16
Mih, N., Brunk, E., Bordbar, A., & Palsson, B. Ø. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005039 · Cited by 16
Nogueira, N. G. D. H. M., de Miranda, D. M., Albuquerque, M. R., Ferreira, B. D. P., Batista, M. T. S., Parma, J. O., Apolinário‐Souza, T., Bicalho, L. E. A., Ugrinowitsch, H., & Lage, G. M. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107157 · Cited by 16
Coker, A. R., Weinstein, D., Vega, T. A., Miller, C. S., Kayser, A. S., & Mitchell, J. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05599-5 · Cited by 16
Sampedro, F., Marín‐Lahoz, J., Martínez‐Horta, S., Camacho, V., López-Mora, D. A., Pagonabarraga, J., & Kulisevsky, J. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.10.016 · Cited by 16
Plasma Sphingomyelins in Late-Onset Alzheimer’s Disease
Fote, G., Wu, J., Mapstone, M. E., Macciardi, F. M., Fiandaca, M. S., & Federoff, H. J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200871 · Cited by 16
van Hooijdonk, C. F. M., Drukker, M., van de Giessen, E., Booij, J., Selten, J., & van Amelsvoort, T. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102265 · Cited by 16
Annerbrink, K., Westberg, L., Olsson, M., Allgulander, C., Andersch, S., Sjödin, I., Holm, G., & Eriksson, E. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.11.022 · Cited by 16
Fernández‐de‐las‐Peñas, C., Ambite‐Quesada, S., Ortiz-Gutiérrez, R. M., Ortega‐Santiago, R., Crujera, A. G., & Caminero, A. B. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.09.007 · Cited by 16
Giorgio, A. D., Caforio, G., Blasi, G., Taurisano, P., Fazio, L., Romano, R., Ursini, G., Gelao, B., Bianco, L. L., Papazacharias, A., et al. (2010) · Psychological Medicine · doi:10.1017/s0033291710002278 · Cited by 16
Katz, A. C., Sarapas, C., Bishop, J. R., Patel, S., & Shankman, S. A. (2014) · Cognition & Emotion · doi:10.1080/02699931.2014.951030 · Cited by 16
Variation in genes involved in dopamine clearance influence the startle response in older adults
Armbruster, D., Mueller‐Alcazar, A., Strobel, A., Lesch, K., Kirschbaum, C., & Brocke, B. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0625-6 · Cited by 17
Taheri, S., Zararsız, G., Karaburgu, S., Borlu, M., Özgün, M. T., Karaca, Z., Tanrıverdi, F., Dündar, M., Keleştimur, F., & Ünlühızarcı, K. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0460 · Cited by 16
Salatino‐Oliveira, A., Murray, J., Kieling, C., Genro, J. P., Polanczyk, G. V., Anselmi, L., Wehrmeister, F. C., Barros, F. C., Menezes, A. M. B., Rohde, L. A., et al. (2016) · Scientific Reports · doi:10.1038/srep29900 · Cited by 16
van Duin, E. D. A., Kasanova, Z., Hernaus, D., Ceccarini, J., Heinzel, A., Mottaghy, F. M., Shali, S. M., Winz, O., Frank, M. J., Beck, M. C. H., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.03.005 · Cited by 16
Fallgatter, A. J., & Lesch, K. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006985 · Cited by 16
Humphreys, K. L., Scheeringa, M. S., & Drury, S. S. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0077 · Cited by 16
Neurogenetics of acute and chronic opiate opioid abstinence treating symptoms and the cause
Blum, K., Gold, M. S., Jacobs, W., McCall, W. V., Febo, M., Baron, D., Dushaj, K., Demetrovics, Z., & Badgaiyan, R. D. (2017) · Frontiers in bioscience · doi:10.2741/4544 · Cited by 16
Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease
Pizzolato, K., Thacker, D. L., Toro-Pagán, N. M. D., Hanna, A., Turgeon, J., Matos, A., Amin, N. S., & Michaud, V. (2021) · Medicina · doi:10.3390/medicina57101107 · Cited by 15
Hartmann, H., Janssen, L. K., Herzog, N., Morys, F., Fängström, D., Fallon, S. J., & Horstmann, A. (2023) · Appetite · doi:10.1016/j.appet.2023.106477 · Cited by 15
Sugiura, L., Toyota, T., Matsuba‐Kurita, H., Iwayama, Y., Mazuka, R., Yoshikawa, T., & Hagiwara, H. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw371 · Cited by 15
Sheikh, H. I., Kryski, K. R., Kotelnikova, Y., Hayden, E. P., & Singh, S. M. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.08.060 · Cited by 15
COMTVal158Met moderates the link between rank and aggression in a non‐human primate
Gutleb, D. R., Roos, C., Noll, A., Ostner, J., & Schülke, O. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12443 · Cited by 15
Asselmann, E., Hertel, J., Beesdo‐Baum, K., Schmidt, C. O., Homuth, G., Nauck, M. A., Grabe, H. J., & Pané‐Farré, C. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.060 · Cited by 15
Danzi, B. A., & Greca, A. M. L. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.03.014 · Cited by 15
Clinical and Experimental Human Sleep-Wake Pharmacogenetics
Landolt, H., Holst, S. C., & Valomon, A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_175 · Cited by 15
Association of COMT gene variability with pain intensity in patients after total hip replacement
Machoy‐Mokrzyńska, A., Starzyńska-Sadura, Z., Dziedziejko, V., Safranow, K., Kurzawski, M., Leźnicka, K., Sulżyc‐Bielicka, V., Jurewicz, A., Bohatyrewicz, A., & Białecka, M. A. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1576920 · Cited by 15
Sex and the dopaminergic system: Insights from addiction studies
Woodcock, E. A., Zakiniaeiz, Y., Morris, E. D., & Cosgrove, K. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00011-4 · Cited by 15
Association of COMT, BDNF and 5-HTT functional polymorphisms with personality characteristics
Tommasi, M., Sergi, M. R., Konstantinidou, F., Franzago, M., Pesce, M., Fratta, I. L., Grilli, A., Stuppia, L., Picconi, L., Saggino, A., et al. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5009 · Cited by 15
Podina, I. R., Popp, R. A., Pop, I. V., & David, D. (2015) · Behavior Therapy · doi:10.1016/j.beth.2015.06.004 · Cited by 15
Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China
Zhang, J., Jin, T., Yunus, Z., Li, X., Geng, T., Wang, H., Cui, Y., & Chen, C. (2014) · BMC Genetics · doi:10.1186/s12863-014-0102-y · Cited by 15
Shibata, K., Diatchenko, L. B., & Zaykin, D. V. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20358 · Cited by 15
Yoo, H. J., Cho, I. H., Park, M., Yang, S. Y., & Kim, S. A. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.9.1403 · Cited by 16
COMT genotype and resting brain perfusion in children
Thomason, M. E., Waugh, C. E., Glover, G. H., & Gotlib, I. H. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.076 · Cited by 15
Perković, M. N., Kiive, E., Erjavec, G. N., Veidebaum, T., Ćurković, M., Dodig‐Ćurković, K., Mück‐Šeler, D., Harro, J., & Pivac, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3138-1 · Cited by 15
Kang, E., Song, Y., Kim, K.-J., Shim, H.-B., Park, J. E., & Yu, B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.008 · Cited by 15
COMTVal158Met andMTHFRC677T moderate risk of schizophrenia in response to childhood adversity
Debost, J.-C., Debost, M., Grove, J., Mors, O. N., HOUGAARD, D. M., Børglum, A. D., Mortensen, P. B., & Petersen, L. V. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12761 · Cited by 15
Semenova, S. A., Rozov, S. V., & Panula, P. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.08.017 · Cited by 15
Dumas, J. A., Makarewicz, J. A., Bunn, J. Y., Nickerson, J. P., & McGee, E. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.009 · Cited by 15
Miranda, G. G., Rodrigue, K. M., & Kennedy, K. M. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.027 · Cited by 15
Ranganathan, M., Aquino, J. P. D., Cortes-Briones, J., Radhakrishnan, R., Pittman, B. P., Bhakta, S. G., & D’Souza, D. C. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05273-5 · Cited by 15
Tang, C., Wang, W., Shi, M., Zhang, N., Zhou, X., Li, X., Ma, C., Chen, G., Xiang, J., & Gao, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00644 · Cited by 15
Arnold, C., Gispert, S., Bonig, H. B., von Wegner, F., Somasundaram, S., & Kell, C. A. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhu330 · Cited by 15
Sun, H., Guo, S., Chen, D., Yang, F., Zou, Y., Di, X.-L., Cao, Y., Kosten, T. R., Lü, L., & Zhang, X. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0841-8 · Cited by 15
Donofry, S. D., Roecklein, K. A., Wildes, J. E., Miller, M. A., Flory, J. D., & Manuck, S. B. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.08.037 · Cited by 15
Suzuki, M., Kurosaki, T., Arai, T., Sawabe, M., Hosoi, T., & Kitamura, T. (2007) · International Journal of Urology · doi:10.1111/j.1442-2042.2007.01822.x · Cited by 15
Different Roles of COMT and HTR2A Genotypes in Working Memory Subprocesses
Kondo, H. M., Nomura, M., & Kashino, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126511 · Cited by 15
Brathwaite, J. M., Costa, L. A. D., & El‐Sohemy, A. (2011) · Journal of Caffeine Research · doi:10.1089/jcr.2011.0015 · Cited by 15
Ge, L., Wu, H., Pan, S., Huang, L., Sun, P. G., Liang, Q., Pang, G.-F., Lv, Z., Hu, C., Liu, C., et al. (2015) · PubMed · Cited by 15
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs
Apud, J. A., & Weinberger, D. R. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.004 · Cited by 15
Self-citationMajor affective disorders and schizophrenia: a common molecular signature?
Bogaert, A. V. D., Del‐Favero, J., & Broeckhoven, C. V. (2006) · Human Mutation · doi:10.1002/humu.20369 · Cited by 15
Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders
Grove, T. B., Taylor, S. F., Dalack, G. W., & Ellingrod, V. L. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.006 · Cited by 14
Park, J. Y., Lengacher, C. A., Reich, R. R., Alinat, C. B., Ramesar, S., Le, A., Paterson, C. L., Pleasant, M. L., Park, H. Y., Kiluk, J. V., et al. (2018) · Translational Behavioral Medicine · doi:10.1093/tbm/iby061 · Cited by 14
Halonen, R., Kuula, L., Lahti, J. M. T., Räikkönen, K., & Pesonen, A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113889 · Cited by 14
The current and potential impact of genetics and genomics on neuropsychopharmacology
Harrison, P. J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.02.005 · Cited by 14
Vermeulen, S. H. H. M., Hermus, A., Blom, H. J., Gellekink, H., Muntjewerff, J.-W., & den Heijer, M. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-05-0381 · Cited by 14
Gibbs, A. A., Naudts, K. H., Azevedo, R. T., & David, A. S. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.007 · Cited by 14
Xing, C., Torres-Caban, M., Wang, T., Lu, Q. L., Xing, G., & Elston, R. C. (2007) · BMC Proceedings · doi:10.1186/1753-6561-1-s1-s95 · Cited by 14
Methionine sulfoxide reductase regulates brain catechol-O-methyl transferase activity
Moskovitz, J., Walss‐Bass, C., Cruz, D. A., Thompson, P. M., & Bortolato, M. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000467 · Cited by 14
Davis, E., Hariri, A. R., Pizzagalli, D. A., & Strauman, T. J. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-3 · Cited by 14
Higashiyama, R. I., Ohnuma, T., Takebayashi, Y., Hanzawa, R., Shibata, N., Yamamori, H., Yasuda, Y., Kushima, I., Aleksić, B., Kondo, K., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32426 · Cited by 14
Tunbridge, E. M., Attenburrow, M.-J., Gardiner, A., Rendell, J., Hinds, C., Goodwin, G. M., Harrison, P. J., & Geddes, J. R. (2017) · Bipolar Disorders · doi:10.1111/bdi.12531 · Cited by 14
Leźnicka, K., Niewczas, M., Kurzawski, M., Cięszczyk, P., Safranow, K., Ligocka, M., & Białecka, M. A. (2017) · Personality and Individual Differences · doi:10.1016/j.paid.2017.12.008 · Cited by 14
COMT Genotype and Sensory and Sensorimotor Gating in High and Low Hypnotizable Subjects
Storozheva, Z. I., Kirenskaya, A. V., Gordeev, M. N., Kovaleva, M. E., & Novototsky-Vlasov, V. Y. (2018) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2018.1396120 · Cited by 14
Enge, S., Sach, M., Reif, A., Lesch, K., Miller, R. E., & Fleischhauer, M. (2019) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-019-00752-w · Cited by 14
Yen, J., Lin, P., Lin, H., Lin, P., Chou, W., & Ko, C. (2021) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12454 · Cited by 14
Deng, Y., Li, M., Wang, H., Li, J., He, X., & Yu, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191710567 · Cited by 14
Genetic and environmental aspects of mathematical disabilities
Канзафарова, Р. Ф., Kazantseva, A. V., & Хуснутдинова, Э. К. (2015) · Russian Journal of Genetics · doi:10.1134/s1022795415010032 · Cited by 14
Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression
Ginsberg, S. D., Che, S., Hashim, A., Zavadil, J., Cancro, R., Lee, S. H., Petkova, E., Sershen, H. W., & Volavka, J. (2011) · Brain Structure and Function · doi:10.1007/s00429-011-0315-z · Cited by 14
Ancín, I., Cabranes, J. A., Vázquez-Álvarez, B., Santos, J. L., Sánchez‐Morla, E. M., García-Jiménez, M. Á., Fernández, C., & Barabash, A. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.552192 · Cited by 14
Piffer, D. (2013) · Anthropological Science · doi:10.1537/ase.130731 · Cited by 14
Sambataro, F., Pennuto, M., & Wolf, R. C. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800672463 · Cited by 14
Shukla, A. A., Jha, M. K., Birchfield, T. R., Mukherjee, S., Gleason, K., Abdisalaam, S., Asaithamby, A., ADAMS-HUET, B. A., Tamminga, C. A., & Ghose, S. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.03.019 · Cited by 14
Balestri, M., Calati, R., Serretti, A., Hartmann, A. M., Konte, B., Friedl, M., Giegling, I., & Rujescu, D. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.020 · Cited by 14
Jelaš, I. G., Dević, I., & Karlović, D. (2018) · Psychiatria Danubina · doi:10.24869/psyd.2018.47 · Cited by 14
Zhao, W., Huang, L., Yang, L., Zhang, Q.-M., Chen, X., Fu, W., Du, B., Deng, X., Ji, F., Xiang, Y., et al. (2020) · Brain and Behavior · doi:10.1002/brb3.1523 · Cited by 14
Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy
Ray, R., Schnoll, R. A., & Lerman, C. E. (2007) · CNS Drugs · doi:10.2165/00023210-200721070-00001 · Cited by 14
Does adult ADHD interact with COMT val 158 met genotype to influence working memory performance?
Biehl, S. C., Gschwendtner, K. M., Guhn, A., Müller, L. D., Reichert, S., Heupel, J., Reif, A., Deckert, J., Herrmann, M. J., & Jacob, C. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0148-8 · Cited by 13
Modulative effects of COMT haplotype on age-related associations with brain morphology
Lee, A., & Qiu, A. (2016) · Human Brain Mapping · doi:10.1002/hbm.23161 · Cited by 13
Kirenskaya, A. V., Storozheva, Z. I., Алексеевна, Г. М., & Sewell, R. D. E. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0881-7 · Cited by 13
Hooten, W. M., Biernacka, J. M., OʼBrien, T. G., Cunningham, J. M., & Black, J. L. (2018) · Pain · doi:10.1097/j.pain.0000000000001400 · Cited by 13
Development of dopaminergic genetic associations with visuospatial, verbal and social working memory
Dumontheil, I., Kilford, E. J., & Blakemore, S. (2019) · Developmental Science · doi:10.1111/desc.12889 · Cited by 13
Concussion-Associated Polygenic Profiles of Elite Male Rugby Athletes
Antrobus, M., Brazier, J., Callus, P. C., Herbert, A. J., Stebbings, G. K., Khanal, P., Day, S. H., Kilduff, L. P., Bennett, M. A., Erskine, R. M., et al. (2022) · Genes · doi:10.3390/genes13050820 · Cited by 13
Tajik, M., & Noseworthy, M. D. (2022) · Brain Disorders · doi:10.1016/j.dscb.2022.100058 · Cited by 13
Catechol‐O‐Methyltransferase Genotype Modulates Opioid Release in Decision Circuitry
Mitchell, J., O’Neil, J. P., Jagust, W. J., & Fields, H. L. (2013) · Clinical and Translational Science · doi:10.1111/cts.12075 · Cited by 13
Estudos de associação genética no transtorno obsessivo-compulsivo
Sampaio, A. S., Lins, R. M. P., Daltro-Oliveira, R., Quarantini, L. D. C., do Rosário, M. C., Miguel, E. C., & Hounie, A. G. (2013) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832013000500003 · Cited by 14
Gong, P., Zhang, H., Chi, W., Ge, W., Zhang, K., Zheng, A., Gao, X., & Zhang, F. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9817-3 · Cited by 13
Zhang, F., Liu, C., Chen, Y., Wang, L., Lu, T., Yan, H., Ruan, Y., Yue, W., & Zhang, D. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0061 · Cited by 13
Polymorphisms and disease: hotspots of inactivation in methyltransferases
Rutherford, K., & Daggett, V. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.03.007 · Cited by 13
Genetic Basis of Sleep in Healthy Humans
Landolt, H., & Dijk, D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00015-3 · Cited by 13
Watanabe, T., Ishiguro, S., Aoki, A., Ueda, M., Hayashi, Y., Akiyama, K., Kato, K., & Shimoda, K. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.1.86 · Cited by 13
Božek, T., Blažeković, A., Perković, M. N., Gotovac, K., Šustar, A., Duvnjak, L. S., Outeiro, T. F., Pivac, N., & Borovečki, F. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0295-0 · Cited by 13
Hooten, W. M., Hu, D., Cunningham, J. M., & Black, J. L. (2019) · Molecular Pain · doi:10.1177/1744806919848929 · Cited by 13
Hein, S., Weeland, J., Square, A., Haeffel, G. J., Chapman, J., Macomber, D., Lee, M., Foley Geib, C., & Grigorenko, E. L. (2020) · International Journal of Law and Psychiatry · doi:10.1016/j.ijlp.2020.101626 · Cited by 12
Metadata
- Authors
- Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., Egan, M. F., Kleinman, J. E., & Weinberger, D. R.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weinberger, Daniel R.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 75
- Issue
- 5
- Pages
- 807-821
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1182110
- OpenAlex
- W2054856852
- Cited by
- 1,675
- References
- 46
- Citations by year
- 2026: 21 · 2025: 39 · 2024: 47 · 2023: 41 · 2022: 68 · 2021: 76 · 2020: 72 · 2019: 102 · 2018: 73 · 2017: 94 · 2016: 110 · 2015: 110 · 2014: 118 · 2013: 109 · 2012: 103
- FWCI
- 17.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3182 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- catechol-O-methyltransferase, COMT Val158Met polymorphism, single nucleotide polymorphisms, prefrontal cortex, dopamine metabolism, schizophrenia, mRNA expression, protein abundance, postmortem brain, lymphocytes
- MeSH terms
- Analysis of Variance, Animals, Catechol O-Methyltransferase, Genotype, Humans, Lymphocytes, Methylation, Proteins, RNA, Messenger, Sex Factors, Genetic Variation, Blotting, Western, Gene Expression Regulation, Enzymologic, Mutagenesis, Site-Directed, Prefrontal Cortex, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.